1-[4-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]phenyl]-2,2,2-trifluoro-ethanone OxiMe
- $675 - $1540
- Product name: 1-[4-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]phenyl]-2,2,2-trifluoro-ethanone OxiMe
- CAS: 87736-77-4
- MF: C15H22F3NO2Si
- MW: 333.42
- EINECS:
- MDL Number:MFCD31563428
- Synonyms:1-[4-[[[(1,1-diMethylethyl)diMethylsilyl]oxy]Methyl]phenyl]-2,2,2-trifluoro-ethanone OxiMe;4-(2,2,2-Trifluoroethyl-1-oxiMe)benzyl Alcohol tert-Butyl(diMethyl)silyl Ether;4-[(tert-butyldimethylsiloxy)methyl]-2,2,2-trifluoroacetophenone oxime;Ethanone, 1-[4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]phenyl]-2,2,2-trifluoro-, oxime
2 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 50mg
- 500mg
- ManufacturerMedical Isotopes, Inc.
- Product number53279
- Product description4-(2,2,2-Trifluoroethyl-1-oxime)benzylAlcoholtert-Butyl(dimethyl)silylEther
- Packaging50mg
- Price$675
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT790280
- Product description4-(2,2,2-Trifluoroethyl-1-oxime)benzylAlcoholtert-Butyl(dimethyl)silylEther
- Packaging500mg
- Price$1540
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 53279 | 4-(2,2,2-Trifluoroethyl-1-oxime)benzylAlcoholtert-Butyl(dimethyl)silylEther | 50mg | $675 | 2021-12-16 | Buy |
TRC | T790280 | 4-(2,2,2-Trifluoroethyl-1-oxime)benzylAlcoholtert-Butyl(dimethyl)silylEther | 500mg | $1540 | 2021-12-16 | Buy |
Properties
Boiling point :327.6±42.0 °C(Predicted)
Density :1.08±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Dichloromethane, Ethyl Acetate, Methanol
pka :9.30±0.11(Predicted)
form :Solid
color :White
Density :1.08±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Dichloromethane, Ethyl Acetate, Methanol
pka :9.30±0.11(Predicted)
form :Solid
color :White
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|